Clinical trial
Sucrase-isomaltase Deficiency as a Cause of Irritable Bowel Syndrome
NCT05159115 is registered in ClinicalTrials.gov with Lovisenberg Diakonale Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sucrase-isomaltase Deficiency as a Cause of Irritable Bowel Syndrome
- Lead sponsor
- Lovisenberg Diakonale Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 14, 2022
- Completion date
- December 31, 2027
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
carbohydrate; malabsorption, functional gastrointestinal disorders, irritable bowel syndrome, sucrase isomaltase deficiency, sucrose intolerance due to sucrase-isomaltase deficiency